Eminent American and global bodies ask US that the move will not only undercut New Delhi's effort to cut poverty, but also detrimental to developing a solar energy industry

A dozen-odd eminent American and international organisations have asked the US to reconsider its decision to drag India to the World Trade Organisation (WTO) over solar energy policy.

Offers Incentives To Local Cos, Yet Drags India To WTO Over Solar Mission

New Delhi: The US has dragged India to the World Trade Organization for its scheme to incentivize locallymade solar cells, but an analysis shows that there are at least half-a-dozen American states that offer additional sops to equipment made or assembled within their jurisdiction.

Finding itself on weak wicket, New Delhi will try to settle a complaint Washington filed in WTO challenging India’s policy on procuring equipments for its National Solar Mission.

The United States on Wednesday filed a challenge with the World Trade Organization over elements of India's national solar program, which it said discriminates against foreign solar products in vio

Issuing licence is totally compliant with multilateral agreements: Sharma

India, on Wednesday, conveyed to the U.S. that it had not violated any multilateral trade agreement by issuing compulsory licence for Bayer’s patented anti-cancer drug Nexavar to a local firm so as to make it affordable. It also asserted that such a move should not be seen as routine by the U.S. The message was conveyed by Commerce and Industry Minister Anand Sharma to U.S. Under Secretary for Economic Growth, Energy and Environment Rober Hormats, who raised concerns over the matter during a meeting here, according to an official.

By adopting a policy decision to switch over to organic farming, Kerala could be chasing a delusion, according to S.Ganesan, chairman, International Treaties Expert Committee, Indian Chemical Council.

Talking to The Hindu on the sidelines of a national seminar on `WTO, FTAs and Impact on Agriculture and Allied Sectors’ organised by the WTO Cell of the Department of Agriculture here on Thursday, he said the organic farming policy announced by Kerala revealed the lack of commercial acumen.

Each of the 3 drugs— Dasatinib Trastuzumab & Ixabepilone—costs 1L for a month’s dose

The government has appointed a panel to look into issues related to compulsory licensing of drugs and whether cheaper versions of cancer medicines Trastuzumab, Ixabepilone and Dasatinib can be launched under the provision, a person with knowledge of the development said. According to the person, the health ministry has sent its proposal regarding compulsory licensing for the three drugs to the Department of Industrial Policy and Promotion (DIPP), which in turn has sought the opinion of the department of pharmaceuticals. Srikant Jena, Minister of State for Chemicals and Fertilisers, however, denied having received any note.